Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists

被引：13

作者：

Li, Fu-Nan ^{[1
]}

Kim, Nam-Jung ^{[1
]}

Paek, Seung-Mann ^{[1
]}

Kwon, Do-Yeon ^{[1
]}

Min, Kyung Hoon ^{[2
]}

Jeong, Yeon-Su ^{[3
]}

Kim, Sun-Young ^{[3
]}

Park, Young-Ho ^{[3
]}

Kim, Hee-Doo ^{[4
]}

Park, Hyeung-Geun ^{[1
]}

Suh, Young-Ger ^{[1
]}

机构：

[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea

[2] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea

[3] Amorepacific R&D Ctr, Yongin 446729, Gyeonggi Do, South Korea

[4] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 10期

关键词：

Diarylalkyl amides; TRPV1; antagonists; VANILLOID RECEPTOR-1; NEUROPATHIC PAIN; CAPSAICIN CREAM; POTENT; EXPRESSION; CONVERSION; DISCOVERY; THIOUREAS; NEURONS; CHANNEL;

D O I：

10.1016/j.bmc.2009.04.010

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

We have developed a new class of diarylalkyl amides as novel TRPV1 antagonists. They exhibited potent Ca-45(2+) uptake inhibitions in rat DRG neuron. In particular, the amide 59 was identified as a potent antagonist with IC50 of 57 nM. The synthesis and structure-activity relationship of the diarylalkyl amides are also described. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：3557 / 3567

页数：11

共 50 条

[31] TRPV1 antagonists as potential antitussive agents
McLeod, Robbie L.
Correll, Craig C.
Jia, Yanlin
Anthes, John C.
LUNG, 2008, 186 (Suppl 1) : S59 - S65
[32] TRPV1 antagonists: a survey of the patent literature
Kyle, Donald J.
Tafesse, Laykea
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (07) : 977 - 996
[33] Discovery of piperidine carboxamide TRPV1 antagonists
Cheung, Wing S.
Calvo, Raul R.
Tounge, Brett A.
Zhang, Sui-Po
Stone, Dennis R.
Brandt, Michael R.
Hutchinson, Tasha
Flores, Christopher M.
Player, Mark R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (16) : 4569 - 4572
[34] TRPV1 antagonists: the challenges for therapeutic targeting
Khairatkar-Joshi, Neelima
Szallasi, Arpad
TRENDS IN MOLECULAR MEDICINE, 2009, 15 (01) : 14 - 22
[35] TRPV1 Antagonists as Potential Antitussive Agents
Robbie L. McLeod
Craig C. Correll
Yanlin Jia
John C. Anthes
Lung, 2008, 186 : 59 - 65
[36] Targeting TRPV1 by antagonists for pain relief
Trevisani, M.
NEUROPEPTIDES, 2009, 43 (05) : 451 - 451
[37] In vitro TRPV1 activity of piperine derived amides
Andres Correa, Edwin
Hogestatt, Edward D.
Sterner, Olov
Echeverri, Fernando
Zygmunt, Peter M.
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (09) : 3299 - 3306
[38] Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists
Appendino, G
Harrison, S
De Petrocellis, L
Daddario, N
Bianchi, F
Moriello, AS
Trevisani, M
Benvenuti, F
Geppetti, P
Di Marzo, V
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (08) : 1417 - 1424
[39] Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists
Gharat, Laxmikant A.
Szallasi, Arpad
EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (02) : 159 - 209
[40] Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade
Gavva, Narender R.
Bannon, Anthony W.
Hovland, David N., Jr.
Lehto, Sonya G.
Klionsky, Lana
Surapaneni, Sekhar
Immke, David C.
Henley, Charles
Arik, Leyla
Bak, Annette
Davis, James
Ernst, Nadia
Hever, Gal
Kuang, Rongzhen
Shi, Licheng
Tamir, Rami
Wang, Jue
Wang, Weiya
Zajic, Gary
Zhu, Dawn
Norman, Mark H.
Louis, Jean-Claude
Magal, Ella
Treanor, James J. S.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01): : 128 - 137

← 1 2 3 4 5 →